Search

Search Results
Results 1471 - 1480 of 1496 for multiple myeloma
  • Revatio
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Revatio intended for persons living in Australia.
  • Cilatil
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • The promise of CAR-T therapy in cancer treatment
    White Paper - 21 Mar 2023
    In this article, Sino Biological discusses the promise of CAR-T therapy in cancer treatment, explaining why this field may lead to huge advances in combating the condition.
  • Advances in the development of antibody production
    White Paper - 21 Mar 2023
    In this article, Sino Biological discusses advances in antibody production and the impact that this could have on therapeutics reagents in modern medicine.
  • New area of cancer research
    White Paper - 16 Mar 2023
    This article explains Cerba Research’s patient and science-driven approach towards cancer research.
  • Cyto-Mine®: Developing an improved hybridoma-based antibody discovery process
    White Paper - 16 Mar 2023
    In this article, Sphere Fluidics demonstrates how its Cyto-Mine® instrument has been crucial in the acceleration of hybridoma-based antibody discovery.
  • Spedra
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Spedra intended for persons living in Australia.
  • Using Chinese hamster ovary cells as a bioprocessing tool
    White Paper - 16 Nov 2022
    This article describes the importance of Chinese Hamster Ovary cells (CHO cells) for scientific discovery and bioprocessing.
  • Caverject Impulse
    Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about Caverject Impulse intended for persons living in Australia.
  • Vedafil
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Vedafil (sildenafil) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback